FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569030058> ?p ?o ?g. }

• W1569030058 endingPage "3583" @default.
• W1569030058 startingPage "3575" @default.
• W1569030058 abstract "BACKGROUND Despite targeted antiemetics, data support an unmet need related to the management of delayed nausea and vomiting (NV). Promising pilot data informed this phase III trial evaluating gabapentin for delayed NV from highly emetogenic chemotherapy (HEC). METHODS Participants were randomized to receive prophylactic treatment with 20 mg of dexamethasone and a 5HT3 receptor antagonist (RA) on the day of chemotherapy, followed by gabapentin 300 mg twice a day and dexamethasone (dex) or placebo and dex after HEC. Gabapentin/placebo was started the day of chemotherapy and continued through day 5 for the first chemotherapy cycle, whereas dex was titrated down on days 2‐4. The primary end point was complete response (CR), defined as no emesis and no use of rescue medications on days 2‐6, using an NV diary. The percentages of those in each group with a CR were compared by Fisher's exact test. RESULTS Four hundred thirty patients were enrolled in this study. Forty‐seven percent of patients in the gabapentin arm and 41% in the placebo arm had a CR ( P = .23). Mean number of emesis episodes was <0.5 daily, and mean nausea severity was < 2 (mild). In both arms, patient satisfaction with NV control was greater than 8 (with 10 being perfectly satisfied). There were no significant differences in unwanted side effects. CONCLUSIONS In this study, gabapentin did not significantly improve delayed NV. Patients were satisfied with the control of their nausea and vomiting irrespective of arm. The use of a 5HT3 RA and dexamethasone provided good control of nausea and vomiting for most patients. Cancer 2014;120:3575–3583 . © 2014 American Cancer Society ." @default.
• W1569030058 created "2016-06-24" @default.
• W1569030058 creator A5008411698 @default.
• W1569030058 creator A5008767553 @default.
• W1569030058 creator A5033847671 @default.
• W1569030058 creator A5033848572 @default.
• W1569030058 creator A5045290402 @default.
• W1569030058 creator A5049992163 @default.
• W1569030058 creator A5067707171 @default.
• W1569030058 creator A5072257104 @default.
• W1569030058 creator A5077437003 @default.
• W1569030058 creator A5079389429 @default.
• W1569030058 creator A5080184636 @default.
• W1569030058 creator A5091491528 @default.
• W1569030058 date "2014-07-09" @default.
• W1569030058 modified "2023-10-16" @default.
• W1569030058 title "Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance)" @default.
• W1569030058 cites W1530830778 @default.
• W1569030058 cites W1561023139 @default.
• W1569030058 cites W1881601848 @default.
• W1569030058 cites W1966546066 @default.
• W1569030058 cites W1985217654 @default.
• W1569030058 cites W1993434718 @default.
• W1569030058 cites W1997707842 @default.
• W1569030058 cites W2000366267 @default.
• W1569030058 cites W2026696272 @default.
• W1569030058 cites W2038333699 @default.
• W1569030058 cites W2049464048 @default.
• W1569030058 cites W2054647499 @default.
• W1569030058 cites W2062415797 @default.
• W1569030058 cites W2109146603 @default.
• W1569030058 cites W2118033984 @default.
• W1569030058 cites W2123267000 @default.
• W1569030058 cites W2130573239 @default.
• W1569030058 cites W2140429392 @default.
• W1569030058 cites W2148594906 @default.
• W1569030058 cites W2150019692 @default.
• W1569030058 cites W2151039173 @default.
• W1569030058 cites W2165395427 @default.
• W1569030058 cites W2167513687 @default.
• W1569030058 cites W2229057528 @default.
• W1569030058 cites W2271920363 @default.
• W1569030058 cites W2324983656 @default.
• W1569030058 doi "https://doi.org/10.1002/cncr.28892" @default.
• W1569030058 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4221473" @default.
• W1569030058 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25043153" @default.
• W1569030058 hasPublicationYear "2014" @default.
• W1569030058 type Work @default.
• W1569030058 sameAs 1569030058 @default.
• W1569030058 citedByCount "19" @default.
• W1569030058 countsByYear W15690300582015 @default.
• W1569030058 countsByYear W15690300582016 @default.
• W1569030058 countsByYear W15690300582017 @default.
• W1569030058 countsByYear W15690300582018 @default.
• W1569030058 countsByYear W15690300582019 @default.
• W1569030058 countsByYear W15690300582020 @default.
• W1569030058 countsByYear W15690300582021 @default.
• W1569030058 countsByYear W15690300582022 @default.
• W1569030058 countsByYear W15690300582023 @default.
• W1569030058 crossrefType "journal-article" @default.
• W1569030058 hasAuthorship W1569030058A5008411698 @default.
• W1569030058 hasAuthorship W1569030058A5008767553 @default.
• W1569030058 hasAuthorship W1569030058A5033847671 @default.
• W1569030058 hasAuthorship W1569030058A5033848572 @default.
• W1569030058 hasAuthorship W1569030058A5045290402 @default.
• W1569030058 hasAuthorship W1569030058A5049992163 @default.
• W1569030058 hasAuthorship W1569030058A5067707171 @default.
• W1569030058 hasAuthorship W1569030058A5072257104 @default.
• W1569030058 hasAuthorship W1569030058A5077437003 @default.
• W1569030058 hasAuthorship W1569030058A5079389429 @default.
• W1569030058 hasAuthorship W1569030058A5080184636 @default.
• W1569030058 hasAuthorship W1569030058A5091491528 @default.
• W1569030058 hasBestOaLocation W15690300582 @default.
• W1569030058 hasConcept C126322002 @default.
• W1569030058 hasConcept C142724271 @default.
• W1569030058 hasConcept C204787440 @default.
• W1569030058 hasConcept C27081682 @default.
• W1569030058 hasConcept C2776608144 @default.
• W1569030058 hasConcept C2776694085 @default.
• W1569030058 hasConcept C2779924295 @default.
• W1569030058 hasConcept C2780401358 @default.
• W1569030058 hasConcept C2780580376 @default.
• W1569030058 hasConcept C2780852908 @default.
• W1569030058 hasConcept C2780884295 @default.
• W1569030058 hasConcept C42219234 @default.
• W1569030058 hasConcept C71924100 @default.
• W1569030058 hasConceptScore W1569030058C126322002 @default.
• W1569030058 hasConceptScore W1569030058C142724271 @default.
• W1569030058 hasConceptScore W1569030058C204787440 @default.
• W1569030058 hasConceptScore W1569030058C27081682 @default.
• W1569030058 hasConceptScore W1569030058C2776608144 @default.
• W1569030058 hasConceptScore W1569030058C2776694085 @default.
• W1569030058 hasConceptScore W1569030058C2779924295 @default.
• W1569030058 hasConceptScore W1569030058C2780401358 @default.
• W1569030058 hasConceptScore W1569030058C2780580376 @default.
• W1569030058 hasConceptScore W1569030058C2780852908 @default.
• W1569030058 hasConceptScore W1569030058C2780884295 @default.
• W1569030058 hasConceptScore W1569030058C42219234 @default.

• next